Skip to main content

Table 1 Characterization of the octreotide(−)/radtech(+) livers, including results from the nNUFTI analyses

From: A novel statistical analysis method to improve the detection of hepatic foci of 111In-octreotide in SPECT/CT imaging

Patient Time of diagnosis (years) Image modality Tumour type Number of metastases nThI PPV
42F 0.0 CT HCC, carcinoid(ECL) Multiple 0.748 1.0
32F 0.3 US Midgut carcinoid Three 0.743 1.0
41F −0.8 CT Midgut carcinoid Single 0.718 1.0
55F −0.4 CT NET, origin unknown Multiple 0.697 1.0
84M 1.0 CT Midgut carcinoid Multiple 0.659 0.50
25M 1.5 CT Medullary thyroid cancer Single 0.655 0.50
43 M 1.4 US, CT Midgut carcinoid Four 0.642 0.35
90M 2.4 CT Medullary thyroid cancer Single 0.641 0.38
30F 2.7 CT Endocrine pancreatic Single 0.637 0.38
109F 1.5 CT Lung carcinoid Single 0.621 0.32
111F 2.6 CT Midgut carcinoid Two 0.619 0.33
104F 0.2 US Midgut carcinoid, cervix cancer Multiple 0.599 0.27
103M −0.1 CT Midgut carcinoid Multiple 0.581 0.26